Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Repurchased
Ratios

Corcept Therapeutics (CORT) Leases (2019 - 2025)

Corcept Therapeutics' Leases history spans 7 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Leases fell 13.92% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 13.92%, while the annual FY2025 figure was $4.6 million, 13.92% down from the prior year.
  • Leases for Q4 2025 was $4.6 million at Corcept Therapeutics, down from $4.8 million in the prior quarter.
  • Across five years, Leases topped out at $5.7 million in Q2 2024 and bottomed at $61000.0 in Q1 2024.
  • The 5-year median for Leases is $1.9 million (2021), against an average of $2.5 million.
  • The largest annual shift saw Leases tumbled 89.62% in 2023 before it skyrocketed 8337.7% in 2025.
  • A 5-year view of Leases shows it stood at $514000.0 in 2021, then skyrocketed by 122.37% to $1.1 million in 2022, then crashed by 89.5% to $120000.0 in 2023, then surged by 4336.67% to $5.3 million in 2024, then decreased by 13.92% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Leases are $4.6 million (Q4 2025), $4.8 million (Q3 2025), and $5.0 million (Q2 2025).